The global next-generation sequencing (NGS) sample preparation industry is poised for remarkable growth, with its valuation projected to rise at a compound annual growth rate (CAGR) of 13.7%, reaching USD 5441.1 Million by 2032. This significant expansion is driven by the increasing adoption of NGS technologies across research, clinical, and diagnostic applications, along with continuous advancements in sample preparation techniques.
NGS sample preparation plays a pivotal role in enabling accurate and efficient sequencing workflows, including DNA/RNA extraction, library preparation, and enrichment processes. The market’s growth is fueled by rising demand for personalized medicine, expanding applications of genomics in disease research, and increasing investment in biotechnology and pharmaceutical sectors. Additionally, the development of automated and user-friendly preparation kits is further enhancing accessibility and driving market adoption.
The healthcare industry’s focus on early disease detection and precision diagnostics, coupled with the integration of NGS into clinical settings, is creating new growth opportunities. Emerging economies, with their expanding research infrastructure and growing interest in genomic technologies, are expected to contribute significantly to the market’s growth trajectory.
A Full Report Analysis – https://www.futuremarketinsights.com/reports/ngs-sample-preparation-market
Key Takeaways:
- Market Growth: The NGS sample preparation market is forecasted to grow at a 13.7% CAGR, reaching USD 5.44 billion by 2032.
- Market Drivers: Increasing adoption of NGS in clinical diagnostics, advancements in preparation technologies, and rising demand for precision medicine are key growth factors.
- Industry Trends: The shift toward automation, miniaturization of sample preparation kits, and the integration of AI-driven workflows are shaping the market’s future.
- Future Outlook: With continued innovations and growing applications in personalized healthcare, the NGS sample preparation market offers substantial opportunities for stakeholders across the life sciences ecosystem.
The expansion of the NGS sample preparation market underscores its vital role in unlocking the potential of genomic research and diagnostics, paving the way for transformative advancements in healthcare and scientific discovery.
Factors Driving Market Growth
- Increased Demand for Genomic Research: The rising interest in genomics and personalized medicine is driving the need for efficient NGS sample preparation techniques.
- Technological Advancements: Continuous innovations in NGS technologies and methodologies are enhancing the efficiency and accuracy of sample preparation processes.
- Growing Applications in Healthcare: The application of NGS in various fields such as oncology, infectious diseases, and genetic disorders is expanding, leading to increased demand for sample preparation solutions.
- Decreasing Costs of Sequencing: As the costs associated with sequencing continue to decline, more research institutions and healthcare facilities are adopting NGS technologies, further boosting the sample preparation market.
- Rising Awareness and Adoption of Precision Medicine: The focus on precision medicine is increasing the demand for advanced genomic testing, which relies heavily on effective sample preparation.
Regional Insights
- The North American market is expected to dominate due to high investments in research and development and a strong presence of key players in the NGS field.
- The Asia-Pacific region is anticipated to witness significant growth driven by rising healthcare investments and an increasing focus on genomics research.
How is the Competition Landscape in the NGS Sample Preparation Market?
Some of the market participants in the global NGS sample preparation market is Thermo Fisher Scientific, Agilent Technologies, Inc., F Hoffman-La Roche AG, Illumina, Inc., Eurofins Scientific and Macrogen, Inc.
Companies in the NGS sample preparation market are utilising new opportunities in the areas of agriculture and animal research in addition to medical services to diversify their revenue sources.
In order to better understand multigenic disorders, companies in the market for NGS sample preparation are expanding their studies into the identification of novel disease genes in animals, in turn, expand the NGS sample preparation market share.
A few of the recent developments in NGS sample preparation market are as follows:
- NGS library preparation systems were introduced by Agilent Technologies and were made to handle difficult DNA sequencing assays.
- NEBNext Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set were introduced by New England Biolabs to enable customizable RNA Depletion.
Key Companies Profiled
- Thermo Fisher Scientific
- Agilent Technologies, Inc.
- F Hoffman-La Roche AG
- Illumina, Inc.
- Eurofins Scientific
- Macrogen, Inc.
Key Segments Profiled in the NGS Sample Preparation Market Survey
By Type:
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Single Molecule Real Time (SMRT) Sequencing
- Nanopore Sequencing
By Application:
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Precision Medicine
- Agriculture and Animal Research
- Other Application
By End Use:
- Biopharmaceutical Companies
- Hospitals
- Research Institutes
- CMOs
- CROs
By Region:
- North America
- Latin America
- Europe
- Asia Pacific & Japan
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube